Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-18

Clinical Trial Update: Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is comparing the efficacy of trelagliptin versus sitagliptin for glycemic control in adults with type 2 diabetes; enrollment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)
  • Trelagliptin (trelagliptin)

Snippet

Sponsor: Khyber Medical College, Peshawar | Conditions: Diabetes Mellitus Type 2, Glycemic Control for Diabetes Mellitus | Phase 3 | Status: ENROLLING_BY_INVITATION